96 research outputs found
The color of artificial light affects mate attraction in the common glow-worm
Artificial light at night, often referred to as βlight pollutionβ, is a global environmental problem that threatens many nocturnal organisms. One such species is the European common glow-worm (Lampyris noctiluca), in which reproduction relies on the ability of sedentary bioluminescent females to attract flying males to mate. Previous studies show that broad-spectrum white artificial light interferes with mate attraction in this beetle. However, much less is known about wavelength-specific effects. In this study, we experimentally investigate how the peak wavelength (color) of artificial light affects glow-worm mate attraction success in the field by using dummy females that trap males landing to mate. Each dummy was illuminated from above by either a blue (peak wavelength: 452 nm), white (449 nm), yellow (575 nm), or red (625 nm) LED lighting, or light switched off in the control. We estimated mate attraction success as both the probability of attracting at least one male and the number of males attracted. In both cases, mate attraction success depended on the peak wavelength of the artificial light, with short wavelengths (blue and white) decreasing it more than long wavelengths (yellow and red). Hence, adjusting the spectrum of artificial light can be an effective measure for mitigating the negative effects of light pollution on glow-worm reproduction
Malignant germ cell tumours of the testis express interferon-Ξ³, but are resistant to endogenous interferon-Ξ³
Activation of Cytotoxic and Regulatory Functions of NK Cells by Sindbis Viral Vectors
Oncolytic viruses (OVs) represent a relatively novel anti-cancer modality. Like other new cancer treatments, effective OV therapy will likely require combination with conventional treatments. In order to design combinatorial treatments that work well together, a greater scrutiny of the mechanisms behind the individual treatments is needed. Sindbis virus (SV) based vectors have previously been shown to target and kill tumors in xenograft, syngeneic, and spontaneous mouse models. However, the effect of SV treatment on the immune system has not yet been studied. Here we used a variety of methods, including FACS analysis, cytotoxicity assays, cell depletion, imaging of tumor growth, cytokine blockade, and survival experiments, to study how SV therapy affects Natural Killer (NK) cell function in SCID mice bearing human ovarian carcinoma tumors. Surprisingly, we found that SV anti-cancer efficacy is largely NK cell-dependent. Furthermore, the enhanced therapeutic effect previously observed from Sin/IL12 vectors, which carry the gene for interleukin 12, is also NK cell dependent, but works through a separate IFNΞ³-dependent mechanism, which also induces the activation of peritoneal macrophages. These results demonstrate the multimodular nature of SV therapy, and open up new possibilities for potential synergistic or additive combinatorial therapies with other treatments
A Novel Copper Chelate Modulates Tumor Associated Macrophages to Promote Anti-Tumor Response of T Cells
At the early stages of carcinogenesis, the induction of tumor specific T cell mediated immunity seems to block the tumor growth and give protective anti-tumor immune response. However, tumor associated macrophages (TAMs) might play an immunosuppressive role and subvert this anti tumor immunity leading to tumor progression and metastasis.The Cu (II) complex, (chelate), copper N-(2-hydroxy acetophenone) glycinate (CuNG), synthesized by us, has previously been shown to have a potential usefulness in immunotherapy of multiple drug resistant cancers. The current study demonstrates that CuNG treatment of TAMs modulates their status from immunosuppressive to proimmunogenic nature. Interestingly, these activated TAMs produced high levels of IL-12 along with low levels of IL-10 that not only allowed strong Th1 response marked by generation of high levels of IFN-gamma but also reduced activation induced T cell death. Similarly, CuNG treatment of peripheral blood monocytes from chemotherapy and/or radiotherapy refractory cancer patients also modulated their cytokine status. Most intriguingly, CuNG treated TAMs could influence reprogramming of TGF-beta producing CD4(+)CD25(+) T cells toward IFN-gamma producing T cells.Our results show the potential usefulness of CuNG in immunotherapy of drug-resistant cancers through reprogramming of TAMs that in turn reprogram the T cells and reeducate the T helper function to elicit proper anti-tumorogenic Th1 response leading to effective reduction in tumor growth
Hypoxia Potentiates Glioma-Mediated Immunosuppression
Glioblastoma multiforme (GBM) is a lethal cancer that exerts potent immune suppression. Hypoxia is a predominant feature of GBM, but it is unclear to the degree in which tumor hypoxia contributes to this tumor-mediated immunosuppression. Utilizing GBM associated cancer stem cells (gCSCs) as a treatment resistant population that has been shown to inhibit both innate and adaptive immune responses, we compared immunosuppressive properties under both normoxic and hypoxic conditions. Functional immunosuppression was characterized based on production of immunosuppressive cytokines and chemokines, the inhibition of T cell proliferation and effector responses, induction of FoxP3+ regulatory T cells, effect on macrophage phagocytosis, and skewing to the immunosuppressive M2 phenotype. We found that hypoxia potentiated the gCSC-mediated inhibition of T cell proliferation and activation and especially the induction of FoxP3+T cells, and further inhibited macrophage phagocytosis compared to normoxia condition. These immunosuppressive hypoxic effects were mediated by signal transducer and activator of transcription 3 (STAT3) and its transcriptionally regulated products such as hypoxia inducible factor (HIF)-1Ξ± and vascular endothelial growth factor (VEGF). Inhibitors of STAT3 and HIF-1Ξ± down modulated the gCSCs' hypoxia-induced immunosuppressive effects. Thus, hypoxia further enhances GBM-mediated immunosuppression, which can be reversed with therapeutic inhibition of STAT3 and HIF-1Ξ± and also helps to reconcile the disparate findings that immune therapeutic approaches can be used successfully in model systems but have yet to achieve generalized successful responses in the vast majority of GBM patients by demonstrating the importance of the tumor hypoxic environment
In vivo assessment of tumor-induced nonspecific suppression of contact sensitivity. I. Correlation with in vitro studies.
Regulation of t-cell mixed lymphocyte reaction reactivity: demonstration of enhancing and inhibitory activity in tumor- bearing host macrophage supernatants.
Reversal of macrophage-augmented mlr reactivity by tumor- -induced splenic suppressor t cells and their soluble factor(s).
Macrophage regulation of the t cell mixed lymphocyte reaction (mlr) during tumor growth. The role of macrophage-derived factors. Abstr.
- β¦